Sol-Gel Technologies (SLGL) EBITDA (2017 - 2026)
Sol-Gel Technologies' (SLGL) quarterly EBITDA came in at $3.9 million in Q1 2026, down 57.49% year-on-year from $9.1 million in Q1 2025, and up 213.02% on a QoQ basis from -$3.4 million in Q4 2025.
Sol-Gel Technologies (SLGL) EBITDA (2017 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has 10 years of EBITDA data on file, last reported at $3.9 million in Q1 2026.
- On a quarterly basis, EBITDA fell 57.49% year-over-year to $3.9 million in Q1 2026; TTM through Mar 2026 was $5.4 million, a 43.02% increase from a year earlier, with the FY2025 full-year figure at -$7.5 million, up 37.26% from the prior year.
- EBITDA for Q1 2026 stood at $3.9 million, up from -$3.4 million in the prior quarter.
- Over the last five years, EBITDA for SLGL reached as high as $11.2 million in Q2 2025 and fell as low as -$6.5 million in Q2 2023.
- Historically, EBITDA has averaged $309941.2 across 5 years, with a median of -$828000.0 in 2024.
- Across the five-year window, EBITDA slumped 1509.72% in 2023 and soared 591.5% in 2025, its largest moves.
- Year by year, EBITDA stood at -$6.2 million in 2022, then increased by 12.86% to -$5.4 million in 2023, then retreated by 12.8% to -$6.1 million in 2024, then surged by 44.07% to -$3.4 million in 2025, then soared by 213.02% to $3.9 million in 2026.
- Per Business Quant data, the three most recent EBITDA figures were $3.9 million in Q1 2026, -$3.4 million in Q4 2025, and -$6.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Sol-Gel Technologies | 227.58 Mn | 217.44 Mn | - | 3.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.86 Mn |
| Dec 31, 2025 | -3.41 Mn |
| Sep 30, 2025 | -6.29 Mn |
| Jun 30, 2025 | 11.23 Mn |
| Mar 31, 2025 | 9.07 Mn |
| Dec 31, 2024 | -6.10 Mn |
| Sep 30, 2024 | -828,000.00 |
| Jun 30, 2024 | 1.62 Mn |
| Mar 31, 2024 | 6.71 Mn |
| Dec 31, 2023 | -5.41 Mn |
| Sep 30, 2023 | -6.31 Mn |
| Jun 30, 2023 | -6.53 Mn |
| Mar 31, 2023 | 11.06 Mn |
| Dec 31, 2022 | -6.21 Mn |
| Sep 30, 2022 | -3.63 Mn |
| Jun 30, 2022 | 463,000.00 |
| Mar 31, 2022 | 5.95 Mn |
| Dec 31, 2021 | 13.96 Mn |
| Sep 30, 2021 | 1.27 Mn |
| Jun 30, 2021 | 8.04 Mn |